Coeptis Therapeutics Holdings Inc. Watch

from 8-K 15 pages Placement Agent Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 15 pages Series B Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 15 pages Series a Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 14 pages Series B Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 14 pages Series a Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 27 pages Warrant Agent Agreement

from S-1/A 14 pages Series B Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from S-1/A 14 pages Series a Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from S-1/A 15 pages Pre-Funded Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from S-1/A 15 pages Underwriter Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc. Warrant Shares: [·] Issuance Date: June[·], 2023

from S-1/A 14 pages Common Stock Purchase Warrant Coeptis Therapeutics Holdings, Inc

from 8-K 20 pages Coeptis Therapeutics Holdings Inc. 2022 Equity Incentive Plan

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended

from 8-K 22 pages Warrant Agreement

from POS AM 22 pages Warrant Agreement

from S-1/A 22 pages Whereas, the Company Is Engaged in an Initial Public Offering (The “Offering”) of Units of the Company’s Equity Securities, Each Such Unit Comprised of One Ordinary Share of the Company, No Par Value Per Share (“Ordinary Shares”), and One Redeemable Public Warrant (As Defined Below) (The “Units”) And, in Connection Therewith, Has Determined to Issue and Deliver Up to 7,500,000 Whole Warrants (Or Up to 8,625,000 Whole Warrants if the Over-Allotment Option (As Defined Below) Is Exercised in Full) to Public Investors in the Offering (The “Public Warrants”). Each Whole Warrant Entitles the Holder Thereof to Purchase One-Half of One Ordinary Share for $11.50 Per Share, Subject to Adjustment as Described Herein; And

from S-1/A 22 pages Warrant Agreement

from S-1/A 5 pages Warrant Certificate